Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
236,833,431
-
Total 13F shares
-
16,954,991
-
Share change
-
-73,291
-
Total reported value
-
$77,991,000
-
Price per share
-
$4.60
-
Number of holders
-
34
-
Value change
-
-$211,472
-
Number of buys
-
22
-
Number of sells
-
8
Institutional Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q1 2018
As of 31 Mar 2018,
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,954,991 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Aisling Capital LLC, Consonance Capital Management LP, Biomark Capital Management Co. LLC, VANGUARD GROUP INC, 683 Capital Management, LLC, Broadfin Capital, LLC, Iguana Healthcare Management, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, and MORGENS WATERFALL VINTIADIS & CO INC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.